1996—2022年中国含益生菌保健食品调查分析
作者:
作者单位:

1.中国疾病预防控制中心营养与健康所,国家卫生健康委员会微量元素与营养重点实验室,北京 100050;2.北京邦尼营策科技有限公司,北京 100050

作者简介:

高慧宇 女 副研究员 研究方向为营养与食品卫生学 E-mail:gaohy@ninh.chinacdc.cn
马姗婕 女 工程师 研究方向为营养与食品卫生学 E-mail:mashanjie@hotmail.com

通讯作者:

王国栋 男 副主任技师 研究方向为营养与食品卫生学 E-mail:wanggd@ninh.chinacdc.cn

中图分类号:

R155

基金项目:

保健食品原料目录研究专项课题(ZBW-2017-BJSP-09);北京市科技计划(Z191100008619006)


Analysis of health food containing probiotics in China during 1996 to 2022
Author:
Affiliation:

1.Key Laboratory of Trace Element Nutrition of National Health Commission,National Institute for Nutrition and Health, Chinese Center for Disease Control and Prevention, Beijing 100050, China;2.Beijing Bonny Marketing and Planning Technology Co., LTD, Beijing 100050, China

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 系统调查中国含益生菌保健食品批准情况,分析菌种使用、功能声称、推荐摄入量和适宜人群分布情况,为益生菌类保健食品管理改革提供参考。方法 调查1996—2022年含益生菌保健食品的审批信息,对含益生菌种类、功能声称、推荐摄入量和适宜人群等信息进行统计分析。结果 1996—2022年中国共批准含益生菌保健食品168个,使用了乳杆菌属和双歧杆菌属的产品分别占82.14%和77.98%,61.31%的产品使用嗜酸乳杆菌,所有的产品均未明确到菌株水平;功能声称以“增强免疫力”“调节肠道菌群”和“通便”的产品居多;益生菌推荐摄入量为0.12~3.63×1011 CFU/d;“免疫力低下者”“肠道菌群失调者”和“便秘者”是最常见的产品适宜食用人群,42.86%的产品未标注不适宜人群,标注不适宜人群的产品中69.79%为婴幼儿。结论 中国含益生菌保健食品目前审批的产品较少,产品标签标示均未明确到菌株水平,与益生菌的科学定义不符;现有产品功能单一,产品功能扩展要依赖高质量的人群试验研究结果;婴幼儿适用产品的审批应当科学谨慎。

    Abstract:

    Objective To systematically investigate the health food containing probiotics approved by the government in China, and analyze the application of strains, function claims, recommended intake and distribution of applicable population, and provide reference for the management reform of probiotics products.Methods The information of health food containing probiotics approved by the government in China from 1996 to 2022 were collected and investigated, including the kinds of probiotics, function claims, recommended intake and the information of applicable populations.Results A total of 168 health foods containing probiotics were approved in China from 1996 to 2022, 82.14% and 77.98% of the products used Lactobacillus and Bifidobacterium respectively, 61.31% of the products used Lactobacillus acidophilus, but all products were not labeled with the level of strain. In terms of function claims, most products claimed “enhancing immunity”, “regulating intestinal flora” and “laxative”. The recommended intake of probiotics ranged from 0.12 to 3.63×1011 CFU/d. Claims such as “immunocompromised people”, “people with intestinal flora imbalance” and “people with constipation” were the most common applicable populations for consumption. 42.86% of the products did not labeled with “the unsuitable population”, and more than 69.79% of the products labeled with “the unsuitable population” targeted at infants and young children.Conclusion There are some approved health food containing probiotics in China, none of which is clearly labeled to the strain level, which is not in line with the scientific definition of probiotics. The existing products are of a single function, product function claim depends on the results of high-quality population studies. The approval of products suitable for infants and young children should be scientific and prudent.

    参考文献
    相似文献
    引证文献
引用本文

高慧宇,马姗婕,张雪松,李保龙,王国栋,向雪松.1996—2022年中国含益生菌保健食品调查分析[J].中国食品卫生杂志,2023,35(4):543-549.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2022-09-15
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-07-03
  • 出版日期:
《中国食品卫生杂志》邮寄地址与联系方式变更通知
关闭